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1. Introduction 
Carbon-l 3 nuclear magnetic resonance (’ 3C nmr) 
spectroscopy has only recently been applied to the 
study of peptides and peptide hormones [ 1,2]. A 
major obstacle to such studies has been the very low 
sensitivity of ’ 3 C nmr. Fourier transform nmr tech- 
niques have extended the useful sensitivity of the 
method to study solutions containing peptide concen- 
trations of 0.05 M to 0.5 M. Since the natural abun- 
dance of ’ 3 C is only l%, isotopic enrichment is capable 
of further enhancing the sensitivity of ’ 3 C nmr spectro- 
scopy. Selective enrichment of peptide hormones offers 
the additional advantage of giving the absolute assign- 
ment of the observed chemical shift values to particular 
carbon atoms in the peptide as recently shown in 
studies on the ’ 3 C resonances of gramicidinS(3). 
Such definite assignments can then be used in the 
interpretation of ’ 3 C experiments which utilize the 
i3 C natural abundance spectra. l5 N enrichment of 
oxytocin has been used to define the assignment of 
NH protons in the proton nmr spectrum of the hor- 
mone [4]. Moreover, l3 C and ’ 5 N enriched hormone 
molecules offer a new approach for characterizing con- 
formational and microdynamical properties of neuro- 
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hypophyseal peptides bound to their physiological 
carrier proteins, the neutophysins [5-81. We describe 
here the synthesis and the ’ 3 C nmr spectra of (85% 
r3 C enriched Gly’) o x y tocin. These results demonstrate 
the usefulness of selective l3 C enrichment of oxytocin 
for extending the working sensitivity of l3 C nmr 
spectroscopy to the millimolar concentration range 
and for assigning unambiguously the ’ 3 C resonances 
which can be observed in the natural abundance spec- 
trum 19-121. 
2. Materials and methods 
Uniformally 85% ’ 3 C enriched amino acids were 
prepared in our laboratory in large scale by biosynthe- 
sis using algae, Spimlina maxima, grown on 85% enrich- 
ed ’ 3 C03HNa [ 131. The synthesis of (85% ’ 3 C enriched 
Gly’) oxytocin was made following the general methods 
of solid phase peptide synthesis [ 14,151. The following 
protected amino acids were obtained from Fox Chemi- 
cal Co., Los Angeles: Boc-Leu, Boc-Pro, Boc-Ile, 
Boc-(S-p-MeO-Bzl)Cys, Boc-(0-Bzl)Tyr, Boc- 
Asn-ONp, and Boc-Gln-ONp. Boc-(85% i3C 
enriched) Gly was prepared from the enriched amino 
acid using the method of Schnabel [ 161. Methylene 
chloride was dried over CaClz for 8 hr prior to its use. 
Triethylamine and DMF were purified by distillation. 
N,N’ dicyclohexylcarbodiimide was used in methylene 
chloride for all couplings except that the protected 
Asn and Gln were incorporated into the growing pep- 
tide chain by reaction of the paranitrophenyl ester 
North-Holland Publishing Company - Amsterdam 
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derivatives in DMF. The ’ 3 C enriched Boc-Gly was 
coupled to the chlorobenzyl-resin (Bio-Beads SX-1, 
0.75 eq. per gm, BioRad Co., Richmond, Calif.) in 
refluxing ethanol in the presence of triethylamine for 
24 hr. Deprotection of the Boc group was made with 
25% TFA in methylene chloride. Neutralization was 
performed using 10% triethylamine in methylene 
chloride. For each residue two cycles of coupling were 
made, each one lasting at least 2 hr in the case of 
diimide coupling and at least 8 hr in the case of active 
paranitrophenyl esters. Cleavage of the final protected 
peptide chain from the resin was effected by ammono- 
lysis according to Manning et al. [ 171 to give the pro- 
tected peptide amide. Deblocking of the protected 
peptide amide was accomplished using anhydrous HF 
containing anisole as described by Sakakibara [ 181. 
Oxidation of the deprotected oxytocin was made using 
potassium ferricyanide [ 191. The product mixture was 
further purified according to Manning [ 171 using 
successively two Sephadex G-l 5 columns (1.2 X 140 
cm) with elution by 50% acetic acid and 0.2 N acetic 
acid, respectively. Pharmacological assays of the final 
product (kindly performed by Professor Jard, College 
de France) showed the product gave 90% of the rat 
blood pressor activity and 100% of the hydroosmotic 
tonic activity of reference oxytocin (gift of Dr Gutt- 
mann, Sandoz, Basel. Thin layer chromatography of 
the final product on cellulose plates in BuOH:acetic 
acid: Hz 0 75: 10: 25 followed by staining with either 
ninhydrin or a stain specific for disulfide groups 
showed a single spot with the mobility of reference 
oxytocin, R, = 0.53. Acid hydrolysis of the product 
for 24 hr in sealed evacuated tubes containing constant 
boiling HCl followed by amino acid analysis using a 
Technicon amino acid analyzer TSM gave: Cys, 2.08; 
Tyr, 0.89; Ile, 0.97; Glu, 1.00; Asp, 0.88; Pro, 1.03; 
Leu, 1.05; Gly, 0.97. Also the synthetic hormone was 
shown to bind to neurophysin II with an affinity simi- 
lar to that of oxytocin as measured by ultraviolet 
absorbance difference spectroscopy [8,20]. 
l3 C nmr spectra were obtained on a Varian XL1 00 
12WG spectrometer operating at 25.5 MHz which was 
interfaced to a Varian 16K 620 f computer. An acquisi- 
tion time of 0.8 set was used for a spectral width of 
5000 Hz with a resolution of 1.25 Hz. Proton noise 
decoupling was made with a Varian Gyrocode spin 
decoupler. Spectra were obtained at 30°C using 10 
mm sample tubes containing 5 mM hormone solutions 
in Dz 0, 0.1 M NaCl, pH 6.8 (uncorrected meter read- 
ing) or in DMSO-d6. The deuterated solvent provided 
an internal deuterium lock signal. Either DMSO-d6 it- 
self or dioxane added to each sample containing Dz 0 
provided an internal reference. Chemical shift values 
relative to internal tetramethylsilane (TMS) were calcu- 
lated on the basis that the chemical shift of dioxane is 
67.4 ppm downfield from external TMS and that the 
difference between external and internal TMS is 0.9 
ppm, and that the central DMSO-d6 resonance is 39.6 
ppm downfield from internal TMS. 
3. Results and discussion 
The ’ 3 C NMR spectrum of (85% ’ 3 C enriched 
Gly9) oxytocin at 5 mg/ml, i.e. 5 mM, in DMSO-d6 
is seen in fig. 1. Such a spectrum represents an exten- 
sion of the working sensitivity of ’ 3 C nmr of peptide 
hormones by at least an order of magnitude above 
natural abundance studies [ 21. The carbonyl region of 
the spectrum between 167 and 177 ppm exhibits three 
resonance peaks as seen for 85% ’ 3 C enriched free 
glycine [ 211. The center peak at 17 1 .O ppm represents 
the chemical shift of the Gly9 carbonyl carbon and it 
arises from molecules which contain a l3 C carbonyl 
carbon but a “C alpha carbon. The two sidepeaks 
represent a doublet which arises from ’ 3 C-” C coupling 
in those Gly9 residues containing ’ 3 C isotopes at both 
the carbonyl and alpha positions. The observed value 
of ’ JracO_ ‘acar is 50.4 Hz. For the Gly9 alpha carbon 
of oxytocin, three peaks centered at 42.1 ppm appear 
in fig. 1 which partially overlap the DMSO-de 
solvent peaks. The confident assignment of the alpha 
carbon peaks was aided by the expected observation 
that ‘J 13co-13c, = ‘J = 50.4 Hz. For 13c,-13m. 
the l3 C enriahed hormone in D20 [5] , the ’ 3 C nmr 
spectrum similarly contained three simple peaks for 
each of the carbonyl and alpha carbons with the chemi- 
cal shift values shown in table 1 and a 13C-13C coupling 
constant of 50.5 Hz. The existence of a single chemical 
shift value for each of the Gly9 carbons of the enriched 
hormone shows that the glycine residue of oxytocin 
either exists in a single conformation or in multiple 
conformations which rapidly interconvert to give the 
single observed peaks. 
The data in table 1 show that in changing solvent 
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Fig. 1. The ‘“C nmr spectrum of 5 mM (85% ‘“C enriched Gly9) oxytocin in DMSO-d,. Spectrum obtained from 16,309 tran- 
sients. Chemical shift values are given as downfield from TMS. 
Table 1 
’ 3C chemical shift values for oxytocin (ppm downfield from internal TMS) 
Compound in DMSO-d, 
(’ 3C enriched Gly9) Oxytocin 
Oxytocin, ’ 3 C natural abundance 
Oxytocin, ’ 3C natural abundance 





Gly9 C, Reference 
42.1 This study 
42.3 Deslauriers et al. [9] a 
44.0 Brewster et al. [ 101 a 
(“C enriched Gly9) Oxytocin 174.0 42.0 This study, pH 6.5 
Oxytocin, ’ “C natural abundance 169.5 42.2 Lyerla and Freedman [ 1 l] b, pH 5.8 
Oxytocin, ’ ‘C natural abundance 174.2 42.4 Walter et al. [ 121, pH 6.6 
Chemical shift values calculated on the basis that reference CS, was reported at 192.8 ppm 
downfield from internal TMS (lo), or that DMSO-d, was at 40.9 ppm from external TMS [9, 
personal communication]. 
Chemical shift values calculated on basis that reference dioxane was reported at 126.1 ppm 
downfield from external TMS [ 1 l] . 
Chemical shift values are given with respect to internal TMS assuming that the difference 
between external and internal TMS is 0.9 ppm. 
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from DMSO-d6 to Dz 0 the carbonyl carbon resonance 
moves downfield by 3.0 ppm while the alpha carbon 
resonance does not change. Such large solvent effects 
on the chemical shift values of carbonyl carbon reso- 
nance have been previously reported for Pro-Leu-Gly 
NH2 [22] and gramicidin-S [3]. Unfortunately, no 
clear correlation between the magnitude of these 
solvent-induced chemical shift changes and the presence 
of intramolecular H-bonds has yet been established. 
The ’ 3 C assignments established here by isotopic 
enrichment of Gly9 in oxytocin are compared in table 
1 with those previously proposed on the basis of natural 
abundance 13C spectra [9- ] 12 . The value of.42.1 ppm 
seen here for the alpha carbon of Gly9 of oxytocin in 
DMSO-d6 seems to confirm the value proposed by 
Deslauriers et al. [9] but disagrees with that of Brewster 
et al. [lo]. The erroneous a-carbon assignment probably 
arose from the employed method of assignment [lo] 
which consisted of studying the chemical shifts of the 
various CBZ-protected intermediate peptides used in 
the synthesis of oxytocin and comparing these values 
to those of oxytocin. Unfortunately, large changes in 
chemical shift values, including the beta carbon reso- 
nances of Cys’ and Cys6 between 40 and 45 ppm, were 
observed when the linear nonapeptide was oxidized to 
form the disulfide linked 20-membered ring, and this 
may have contributed ambiguity to the analyses [9, lo]. 
Interestingly, Brewster et al. [lo] showed using [2H] Gly 
that the alpha carbon of Gly9 in the protected nona- 
peptide has a chemical shift of 42.0 ppm, i.e. the same 
value (’ 0.1 ppm) as established here using ’ 3 C enriched 
(Gly9) oxytocin. Brewster et al. then suggested that 
ring closure at Cys’ and Cys6 causes a 1.9 ppm down- 
field shift of the alpha carbon of Gly9, a rather large 
shift which is not easily rationalized. For the carbonyl 
carbon of Gly9 of oxytocin in D2 0, the proposed 
tentative assignment of Lyerla and Freedman [ 111 
based on comparison to amino acid chemical shifts is in 
disagreement by 4.5 ppm with the chemical shift value 
established here (table 1). Consequently, it is clear that 
unambiguous assignments of nmr resonances are best 
made in the case of peptide hormones of the size of 
oxytocin by specific i3 C isotopic substitution. 
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